REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/23/2026
Back to search
Official data from USPTO
OPUS MEDSTRATEGIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/24/2026
Trademark type
Combined
Nice classes
35, 36
Filing date
12/28/2017
Registration date
03/23/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/23/2021
Last transaction
03/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/22/2018
First use in commerce
01/22/2018
Drawing code
5
Owner type
03
Owner location
ELGIN, IL, US
Examiner
FLOWERS, JAY K
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "OPUS" in large letters and partially over top of the stylized wording "MEDSTRATEGIES" in smaller letters.
Holders and representatives
Holders
HINES & ASSOCIATES INC.
OPUS MEDSTRATEGIES INC.
S. I. (pessoa física)
Representatives
Theodore A. Breiner BREINER & BREINER, L.L.C.
Technical classification
Nice Classes
Class 35Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Cost management for the health care benefit plans of others; health care cost containment; including repricing of medications; business and management consulting for healthcare providers and related businesses; consulting in the fields of healthcare operations management and hospital operations management; all of said services excluding pharmacy benefit management services
Class 36
Claims adjustment in the field of health insurance; claims administration services in the field of health insurance; all of said services excluding pharmacy benefit management services
Publications
History of USPTO decisions and trademark events.
31 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/20/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/23/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/16/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/15/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/12/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/11/2021
IUAF
USE AMENDMENT FILED
01/26/2021
EISU
TEAS STATEMENT OF USE RECEIVED
01/26/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/28/2020
TMBN
TTAB RELEASE CASE TO TRADEMARKS
06/15/2020
OP.T
OPPOSITION TERMINATED NO. 999999
06/15/2020
OP.D
OPPOSITION DISMISSED NO. 999999
06/13/2020
OP.I
OPPOSITION INSTITUTED NO. 999999
01/22/2019
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
08/23/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/24/2018
PUBO
PUBLISHED FOR OPPOSITION
07/24/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/04/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/19/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/18/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/18/2018
ALIE
ASSIGNED TO LIE
06/12/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/31/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/31/2018
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
03/24/2018
GPRA
PRIORITY ACTION E-MAILED
03/24/2018
CPRA
PRIORITY ACTION WRITTEN
03/24/2018
DOCK
ASSIGNED TO EXAMINER
03/19/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/13/2018
NWAP
NEW APPLICATION ENTERED
01/02/2018
Continuous trademark protection
Get notified about every new filing that threatens OPUS MEDSTRATEGIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.